Long COVID Research Moonshot Act

The Long COVID Research Moonshot Act establishes a dedicated research program within the National Institutes of Health to accelerate scientific understanding of Long COVID, a condition affecting people who experience persistent symptoms after initial COVID-19 infection. The bill creates a Director position with specific qualifications, requires an annual research plan with input from patients and experts, and mandates a public registry for Long COVID clinical trials. It allocates $1 billion annually from 2025-2034 for this research, along with additional funding for public health surveillance, patient education, and clinical care initiatives. The law includes provisions for expedited research funding, fair drug pricing requirements, and a patient-inclusive advisory board to guide research priorities.